Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 13900-12-4
2. Butethamate Citrate Salt
3. 2-diethylaminoethyl 2-phenylbutyrate Citrate Salt
4. 2-(diethylamino)ethyl 2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate(1:x)
5. Mls000069529
6. 2-(diethylamino)ethyl 2-phenylbutanoate;2-hydroxypropane-1,2,3-tricarboxylic Acid
7. Nsc-11781
8. 3639-12-1
9. Smr000058633
10. 70430r0x79
11. Convenil
12. 2-(diethylamino)ethyl 2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate
13. Heliphenicol (tn)
14. Einecs 237-671-6
15. Opera_id_627
16. Schembl317018
17. Butethamate Citrate [mi]
18. Chembl1516619
19. Regid_for_cid_117176
20. Dtxsid40930276
21. Hms2233l21
22. Hms3369n04
23. Unii-70430r0x79
24. Butetamate Citrate [mart.]
25. Amy31895
26. Butetamate Citrate [who-dd]
27. Nsc11781
28. Mfcd00035572
29. Nsc 11781
30. Akos024319080
31. Beta-diethylaminoethyl-2-phenylbutyrate
32. As-74754
33. Db-042460
34. Butethamate Citrate Salt, Analytical Standard
35. Cs-0358831
36. Ft-0636977
37. D07502
38. D83895
39. J-007208
40. .beta.-(diethylamino)ethyl Ethylphenylacetate Citrate
41. Q27265823
42. Butyric Acid, 2-(diethylamino)ethyl Ester, Citrate (1:1)
43. Diethyl(2-(2-phenylbutyroyloxy)ethyl)ammonium Dihydrogen Citrate
44. 2-(diethylamino)ethyl 2-phenylbutanoate; 2-hydroxypropane-1,2,3-tricarboxylic Acid
45. 2-(diethylamino)ethyl2-phenylbutanoate2-hydroxypropane-1,2,3-tricarboxylate(1:x)
46. 2-hydroxypropane-1,2,3-tricarboxylic Acid--2-(diethylamino)ethyl 2-phenylbutanoate (1/1)
47. Benzeneacetic Acid, .alpha.-ethyl-, 2-(diethylamino)ethyl Ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
48. Benzeneacetic Acid, 2-(diethylamino)ethyl Ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
49. Benzeneacetic Acid, Alpha-ethyl-, 2-(diethylamino)ethyl Ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
| Molecular Weight | 455.5 g/mol |
|---|---|
| Molecular Formula | C22H33NO9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 14 |
| Exact Mass | 455.21553163 g/mol |
| Monoisotopic Mass | 455.21553163 g/mol |
| Topological Polar Surface Area | 162 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 473 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Butetamate Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butetamate Citrate, including repackagers and relabelers. The FDA regulates Butetamate Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butetamate Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butetamate Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butetamate Citrate supplier is an individual or a company that provides Butetamate Citrate active pharmaceutical ingredient (API) or Butetamate Citrate finished formulations upon request. The Butetamate Citrate suppliers may include Butetamate Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Butetamate Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Butetamate Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butetamate Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butetamate Citrate GMP manufacturer or Butetamate Citrate GMP API supplier for your needs.
A Butetamate Citrate CoA (Certificate of Analysis) is a formal document that attests to Butetamate Citrate's compliance with Butetamate Citrate specifications and serves as a tool for batch-level quality control.
Butetamate Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Butetamate Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butetamate Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Butetamate Citrate EP), Butetamate Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butetamate Citrate USP).
LOOKING FOR A SUPPLIER?
